ANAPC1P5

Across TCGA pan-cancer cohorts, ANAPC1P5 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated ANAPC1P5 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher ANAPC1P5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ANAPC1P5 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

THCA, UCS, and BLCA are the cancer types where ANAPC1P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.939	0.995	<.001	117	view →
UCS	OS	Tertile	All	0.128	0.698	<.001	108	view →
BLCA	DFS	Tertile	All	0.159	0.509	.001	63	view →
STAD	OS	Tertile	III,IV	0.726	0.514	<.001	46	view →
DLBC	DFS	Tertile	III,IV	0.074	0.984	.003	40	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
LIHC	DFS	Tertile	II,III,IV	0.195	0.441	.003	30	view →
COAD	DFS	Tertile	III,IV	0.280	0.666	.001	21	view →
SKCM	OS	Tertile	All	0.805	0.880	.018	9	view →
PCPG	DFS	Tertile	All	0.653	0.910	.015	9	view →
TGCT	DFS	Tertile	All	0.407	0.699	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

ANAPC1P5–THCA (OS)

Open the THCA breakdown →